Corrigendum to “Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model”(Heliyon, (2023), 9, 5, (e16217), (S2405844023034242), 10.1016/j.heliyon.2023.e16217)

Post-publication, an investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team identified a concern around the authenticity of the following figures/image panels: Fig. 5 panel A, Bevacizumab-week1 appears to depict the same source image as another published source ‘Progress in Orthodontics, 2023 Oct 16; 24:33[Page: 9], 10.1186/s40510-023-00486-z’, but are described as representing different experimental samples. The authors were requested to provide comment on these concerns, as well as the original unprocessed image files to aid investigation. The authors have clarified that the image was unintentionally duplicated in the two articles due to human error during the preparation of the final layout, after the data analysis. The authors have provided the correct figure as below. The original published Fig. 5 can be found below:[Figure presented] Fig. 5 panel A, Bevacizumab-week1 has been corrected with the following:[Figure presented] The correct version of Fig. 5 should be as below:[Figure presented] The authors apologize for the error.